Rowlandmiller & Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $327K | Hold |
3,562
| – | – | 0.06% | 129 |
|
|
2026
Q1 | $304K | Hold |
3,562
| – | – | 0.06% | 133 |
|
|
2025
Q4 | $281K | Hold |
3,562
| – | – | 0.05% | 139 |
|
|
2025
Q3 | $285K | Hold |
3,562
| – | – | 0.06% | 132 |
|
|
2025
Q2 | $324K | Hold |
3,562
| – | – | 0.07% | 126 |
|
|
2025
Q1 | $334K | Hold |
3,562
| – | – | 0.07% | 122 |
|
|
2024
Q4 | $324K | Hold |
3,562
| – | – | 0.07% | 123 |
|
|
2024
Q3 | $370K | Hold |
3,562
| – | – | 0.08% | 118 |
|
|
2024
Q2 | $346K | Hold |
3,562
| – | – | 0.08% | 119 |
|
|
2024
Q1 | $321K | Sell |
3,562
-150
| -4% | -$12.7K | 0.07% | 123 |
|
|
2023
Q4 | $296K | Hold |
3,712
| – | – | 0.07% | 130 |
|
|
2023
Q3 | $264K | Hold |
3,712
| – | – | 0.07% | 131 |
|
|
2023
Q2 | $286K | Buy |
3,712
+17
| +0.5% | +$1.32K | 0.07% | 127 |
|
|
2023
Q1 | $278K | Buy |
3,695
+133
| +4% | +$9.89K | 0.07% | 129 |
|
|
2022
Q4 | $282K | Hold |
3,562
| – | – | 0.07% | 127 |
|
|
2022
Q3 | $250K | Hold |
3,562
| – | – | 0.07% | 129 |
|
|
2022
Q2 | $285K | Hold |
3,562
| – | – | 0.07% | 122 |
|
|
2022
Q1 | $270K | Hold |
3,562
| – | – | 0.06% | 129 |
|
|
2021
Q4 | $304K | Hold |
3,562
| – | – | 0.07% | 129 |
|
|
2021
Q3 | $261K | Hold |
3,562
| – | – | 0.09% | 105 |
|
|
2021
Q2 | $290K | Hold |
3,562
| – | – | 0.07% | 124 |
|
|
2021
Q1 | $281K | Hold |
3,562
| – | – | 0.07% | 123 |
|
|
2020
Q4 | $305K | Sell |
3,562
-75
| -2% | -$6.2K | 0.09% | 114 |
|
|
2020
Q3 | $241K | Buy |
3,637
+75
| +2% | +$5.72K | 0.1% | 98 |
|
|
2020
Q2 | $261K | Sell |
3,562
-75
| -2% | -$5.33K | 0.09% | 105 |
|
|
2020
Q1 | $241K | Buy |
3,637
+75
| +2% | +$5.29K | 0.1% | 98 |
|
|
2019
Q4 | $245K | Hold |
3,562
| – | – | 0.08% | 103 |
|
|
2019
Q3 | $263K | Hold |
3,562
| – | – | 0.09% | 100 |
|
|
2019
Q2 | $255K | Hold |
3,562
| – | – | 0.09% | 101 |
|
|
2019
Q1 | $244K | Hold |
3,562
| – | – | 0.09% | 99 |
|
|
2018
Q4 | $212K | Hold |
3,562
| – | – | 0.09% | 99 |
|
|
2018
Q3 | $238K | Hold |
3,562
| – | – | 0.09% | 106 |
|
|
2018
Q2 | $231K | Hold |
3,562
| – | – | 0.09% | 102 |
|
|
2018
Q1 | $255K | Hold |
3,562
| – | – | 0.1% | 95 |
|
|
2017
Q4 | $269K | Hold |
3,562
| – | – | 0.11% | 99 |
|
|
2017
Q3 | $259K | Hold |
3,562
| – | – | 0.11% | 97 |
|
|
2017
Q2 | $264K | Hold |
3,562
| – | – | 0.11% | 93 |
|
|
2017
Q1 | $261K | Hold |
3,562
| – | – | 0.12% | 94 |
|
|
2016
Q4 | $233K | Hold |
3,562
| – | – | 0.11% | 94 |
|
|
2016
Q3 | $264K | Sell |
3,562
-120
| -3% | -$8.87K | 0.12% | 89 |
|
|
2016
Q2 | $269K | Sell |
3,682
-136
| -4% | -$9.68K | 0.12% | 92 |
|
|
2016
Q1 | $270K | Buy |
3,818
+56
| +1% | +$3.73K | 0.13% | 93 |
|
|
2015
Q4 | $243K | Hold |
3,762
| – | – | 0.12% | 92 |
|
|
2015
Q3 | $238K | Hold |
3,762
| – | – | 0.13% | 92 |
|
|
2015
Q2 | $246K | Hold |
3,762
| – | – | 0.12% | 94 |
|
|
2015
Q1 | $259K | Sell |
3,762
-70
| -2% | -$4.84K | 0.13% | 94 |
|
|
2014
Q4 | $265K | Buy |
+3,832
| New | +$259K | 0.13% | 89 |
|
Other funds holding CL
SP
PAM
CIM
ECSS
Rowlandmiller & Partners's CL Position: Q2 2026 in Review
Rowlandmiller & Partners held its Colgate-Palmolive (CL) position steady in Q2 2026 at 3,562 shares worth $327K. The position accounts for 0.06% of the portfolio, ranked #129.
Rowlandmiller & Partners first reported a position in CL in Q4 2014 and has held it in 47 quarters since. The position peaked at $370K in Q3 2024. 895 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Rowlandmiller & Partners held 3,562 shares of Colgate-Palmolive worth $327K as of Q2 2026.
- Rowlandmiller & Partners left its Colgate-Palmolive share count unchanged in Q2 2026.
- Colgate-Palmolive made up 0.06% of Rowlandmiller & Partners's portfolio in Q2 2026, its #129 holding.
- Rowlandmiller & Partners first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 47 quarters since.
- Rowlandmiller & Partners's Colgate-Palmolive position peaked at $370K in Q3 2024.
- 895 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.